A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

par Lieberman, Jeffrey A, Dunbar, Geoffrey, Segreti, Anthony C, Girgis, Ragy R, Seoane, Frances, Beaver, Jessica S, Duan, Naihua, Hosford, David A
Publié 2013

Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies

par Miki, Takafumi, Zwingman, Theresa A., Wakamori, Minoru, Lutz, Cathy M., Cook, Susan A., Hosford, David A., Herrup, Karl, Fletcher, Colin F., Mori, Yasuo, Frankel, Wayne N., Letts, Verity A.
Publié 2008

Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia

par Walling, David, Marder, Stephen R., Kane, John, Fleischhacker, W. Wolfgang, Keefe, Richard S. E., Hosford, David A., Dvergsten, Chris, Segreti, Anthony C., Beaver, Jessica S., Toler, Steven M., Jett, John E., Dunbar, Geoffrey C.
Publié dans Schizophr Bull (2016)